RAS seals fate in AML besieged by FLT3 and BCL2 inhibitors
- Author(s)
- Wei, AH;
- Details
- Publication Year 2026-09-17,Volume 148,Issue #12,Page 1521-1522
- Journal Title
- Blood
- Publisher
- ASH
- Research Division(s)
- Blood Cells and Blood Cancer
- PubMed ID
- 42752833
- Publisher's Version
- https://doi.org/10.1182/blood.2026034877
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-10-02 08:19:00
Last Modified: 2026-10-02 08:19:08